Sun Pharma and NIV join forces to fight zika, chikungunya & dengue

Sun Pharma and the Pune-based National Institute of Virology (NIV), an institution of the Indian Council of Medical Research (ICMR), have signed an agreement for testing phytopharmaceutical, biologic and chemical entities developed by Sun Pharma against zika, chikungunya and dengue viruses. Sun Pharma will provide drug molecules to NIV for testing against zika, chikungunya and dengue in model systems. Candidate molecules with encouraging data will then be taken forward for commercial development.

“Our agreement with NIV for developing drugs against zika, chikungunya and dengue is part of our broader commitment for developing new and improved vaccines and drugs against arboviruses that